News

IO Biotech's Leadership to Showcase Innovations at Major Conferences

IO Biotech's Leadership to Showcase Innovations at Major Conferences

IO Biotech's Conference Participation Overview

IO Biotech, a leading clinical-stage biopharmaceutical company, is making strides in the cancer treatment landscape with its innovative immune-modulatory therapeutic vaccines. The company's participation in prominent conferences underscores its commitment to sharing advancements and insights within the oncology sector.

Fireside Chat at Cowen Oncology Summit

At the upcoming TD Cowen 6th Annual Oncology Summit, scheduled for May 27-28, 2025, Mai-Britt Zocca, PhD, President and CEO of IO Biotech, will engage in a fireside chat alongside Amy Sullivan, CFO, and Qasim Ahmad, MD, CMO. This engaging dialogue aims to offer insights into the company’s innovative approach to developing therapeutic cancer vaccines, bolstering confidence among investors and stakeholders about the future of cancer immunotherapy.

Session Details

The fireside chat is set for Tuesday, May 27, 2025, at 10:30 AM EST. Attendees can listen to the discussion through a live webcast, making this event accessible to a broader audience interested in oncology advancements.

Presentation at Jefferies Global Healthcare Conference

In addition to the Cowen Summit, the team from IO Biotech will also showcase their groundbreaking work at the Jefferies Global Healthcare Conference from June 3-5, 2025. Dr. Zocca will present the latest updates on IO Biotech's clinical pipeline, specifically focusing on Cylembio and other promising candidates under development.

Key Presentation Information

Scheduled for June 4, 2025, at 7:35 AM EST, Dr. Zocca's presentation will delve into the company’s innovative therapies and ongoing clinical trials. Participants will have the opportunity to engage in one-on-one meetings to discuss potential investment opportunities and the future of IO Biotech's research endeavors.

Understanding Cylembio®: A Transformative Approach

Cylembio® represents a pivotal advancement in the field of cancer therapy. It is designed to eradicate both cancerous and immunosuppressive cells within the tumor microenvironment by recruiting and activating T cells against specific cellular targets such as IDO1 and PD-L1. This strategic immunotherapy aims to enhance patient outcomes significantly.

Clinical Trials and Collaborations

Currently, IO Biotech is in the midst of conducting several critical clinical trials for Cylembio. The pivotal Phase 3 trial, along with multiple Phase 2 studies, investigates its efficacy in conjunction with Merck’s anti-PD-1 therapy, KEYTRUDA®. The company not only maintains full global commercial rights to Cylembio but is also collaborating with Merck in these studies, ensuring that patients receive leading-edge treatment options.

About IO Biotech

Headquartered in Copenhagen, Denmark, with a presence in New York, IO Biotech is at the forefront of developing novel cancer vaccines. Their T-win® platform represents a sophisticated method of activating T cells to combat tumor cells effectively. As they move forward with additional clinical trials, the company is set on expanding its pipeline and enhancing its therapeutic offerings.

Contact Information

For more inquiries, stakeholders can reach out to:

Investors
Maryann Cimino, Director of Investor Relations
IO Biotech, Inc.
617-710-7305
mci@iobiotech.com

Media
Julie Funesti
Edelman
917-498-1967
julie.funesti@edelman.com

Frequently Asked Questions

What is Cylembio®?

Cylembio® is an investigational therapeutic cancer vaccine designed to stimulate T cells and target both tumor and immunosuppressive cells.

Who will be participating in the Cowen Oncology Summit?

Mai-Britt Zocca, PhD, Amy Sullivan, CFO, and Qasim Ahmad, MD, CMO from IO Biotech will participate in the fireside chat.

What is the significance of the Jefferies Global Healthcare Conference?

This conference provides a platform for IO Biotech to present their latest research findings and engage with potential investors.

How can I access the conference webcasts?

Webcasts for both events will be made available on the Investors section of IO Biotech's website following the conferences.

How does IO Biotech's research impact cancer treatment?

IO Biotech's innovative approach to cancer vaccines aims to enhance patient outcomes by effectively activating the immune response against tumors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 56

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 280

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 159

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 118

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 150

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 21

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 192

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading

Top 5 Most Recently Viewed Articles

The Little Gym Gains Prestige in Entrepreneur’s Franchise Rankings

Updated Category News Views 157

The Little Gym Recognized for Franchise Excellence The Little Gym, renowned for its child enrichment and development programs, recently achieved the impressive milestone of securing the No. 125 spot on Entrepreneur's prestigious Franchise 500 list. This acknowledgment is a testament to the brand's tremendous efforts following a year marked by impressive growth and...

Continue Reading
Grupo Financiero Galicia Launches Major Secondary ADS Offering

Updated Category News Views 173

Grupo Financiero Galicia S.A. Announces Secondary Offering Grupo Financiero Galicia S.A. (Nasdaq: GGAL), recognized as one of Argentina's foremost financial services groups, has launched a significant underwritten secondary offering. This offering, being executed by HSBC Bank plc, includes 11,721,449 American Depositary Shares (ADSs), which correspond to 117,214,490 Class...

Continue Reading
NASCAR Car Wash Unveils New Location in Exciting Celebration

Updated Category News Views 576

NASCAR Car Wash Celebrates Its Latest Opening NASCAR Car Wash is thrilled to announce the grand opening of its newest facility located at 1921 Mount Gallant Road. The event is set to be an exciting day, filled with festivities that cater to both car enthusiasts and the general public. On this special occasion, guests can participate in an array of activities, including...

Continue Reading
AppLovin: Pioneering E-Commerce Opportunities in Gaming

Updated Category News Views 315

AppLovin's Strategic Role in Mobile Gaming AppLovin Corporation (NASDAQ: APP) is taking significant steps to reshape the mobile gaming landscape into a hub for e-commerce engagement. This development comes at a time when digital advertising is on the rise, and analysts see AppLovin as a key player in facilitating this transformation. Strong Growth Potential for E-Commerce...

Continue Reading
Japan's Economic Momentum Shifts Amid Global Concerns

Updated Category News Views 308

Japan's Economic Landscape: A Moderate Recovery Japan is experiencing a gradual recovery in its economy, as confirmed by the latest assessments from the government. Though growth appears steady, there are underlying concerns about global economic conditions and fluctuations within financial markets that warrant attention. Employment and Income Driving Growth The Cabinet...

Continue Reading